Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients.

ABSTRACT:

Background

COVID-19 is a viral disease caused by a new strain of corona virus. Currently, prognosis and risk stratification of COVID-19 patients is done by the disease's clinical presentation. Therefore, identifying laboratory biomarkers for disease prognosis and risk stratification of COVID-19 patients is critical for prompt treatment. Therefore, the main objective of this study was to assess the risk stratification and prognostic value of basic coagulation parameters and factors associated with disease severity among COVID-19 patients at the Tibebe Ghion Specialized Hospital, COVID-19 treatment center, Northwest Ethiopia.

Methods

A follow-up study was conducted among conveniently recruited COVID-19 patients attended from March to June 2021. Socio-demographic and clinical d

SUBMITTER: Tekle E 

PROVIDER: S-EPMC9371343 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature